Topics
Gliomas | Treatment | Immunotherapy | Vaccines
Home > Publications > Topics > Gliomas > Treatment > Immunotherapy > Vaccines
Amanzadeh Jajin E, Oraee Yazdani S, Zali A, Esmaeili A.
Efficacy
and Safety of Vaccines After Conventional Treatments for Survival
of Gliomas: A Systematic Review and Meta-Analysis.
Oncol
Rev. 2024 Apr 19;18:1374513. doi:
10.3389/or.2024.1374513. PMID:
38707486. Review; Meta-Analysis. ˍ
Zhao B, Yao L, Hatami M, Ma W, Skutella T.
Vaccine-based
immunotherapy and related preclinical models for glioma.
Trends
Mol Med. 2024 Jul 15:S1471-4914(24)00167-9. doi:
10.1016/j.molmed.2024.06.009. PMID:
39013724. Review. ˍ
*Phung LH, Nejo T, Okada H.
Lessons
from Post-Immunotherapy Tumor Tissues in Clinical Trials: How Can
We Fuel the Tumor Microenvironment in Gliomas?
Vaccines
(Basel). 2024 Aug 1;12(8):862. doi:
10.3390/vaccines12080862. PMID:
39203988. Review. ˍ
Mao M, Yang W, Zhang X.
Current
mRNA-Based Vaccine Strategies for Glioma Treatment.
Crit
Rev Oncol Hematol. 2024 Aug 7:104459. doi:
10.1016/j.critrevonc.2024.104459. PMID:
39097247. Review˰ ˍ
Andrew Awuah W, Shah MH, Tan JK, Ranganathan S, Sanker V, Darko K,
Tenkorang PO, Adageba BB, Ahluwalia A, Shet V, Aderinto N, Kundu
M, Abdul-Rahman T, Atallah O.
Immunotherapeutic
advances in glioma management: The rise of vaccine-based
approaches.
CNS
Neurosci Ther. 2024 Aug 30;30(9):e70013. doi:
10.1111/cns.70013. PMID:
39215399. Review. ˍ
Zhang T, Jiang S, Zhang L, Liu Y, Zheng H, Zhao H, Du S, Xu Y, Lu
X.
A
bibliometric analysis of oncolytic
virotherapy combined with immunotherapy.
Hum
Vaccin Immunother. 2024
Oct 14;20(1):2406621. doi: 10.1080/21645515.2024.2406621.
PMID:
39400287. Bibliometric analysis. ˍ